Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Loewenberg LS A new sequential oral contraceptive evaluated. 1966 Pa Med pmid:5900565
Smith BD and Bradbury JT Influence of progestins on ovarian responses to estrogen and gonadotrophins in immature rats. 1966 Endocrinology pmid:5904766
Stoll BA Therapy by progestational agents in advanced breast cancer. 1966 Med. J. Aust. pmid:5906684
Poel WE Pituitary tumors in mice after prolonged feeding of synthetic progestins. 1966 Science pmid:4288164
Soska J and Srácek J [Our experience with orally administered norethisterone in the prevention of climacteric metrorrhagia]. 1966 Cesk Gynekol pmid:5930091
Drobis D [Bleeding disorders in white women in tropical areas]. 1966 Cesk Gynekol pmid:5930106
Callantine MR et al. Action of an estrogen antagonist on reproductive mechanisms in the rat. 1966 Endocrinology pmid:5950485
Wynn JW et al. Some effects of oral contraceptives on serum-lipid and lipoprotein levels. 1966 Lancet pmid:4162056
Wentz WB et al. Marginal-dose contraception in the puerperium. 1966 Obstet Gynecol pmid:5950532
Larsson-Cohn U Transaminase activity during oral contraceptive therapy. 1966 Acta Obstet Gynecol Scand pmid:5943038
Board JA Sequential mestranol-norethindrone for oral contraception. 1966 Obstet Gynecol pmid:5325601
Thulin KE and Nermark J Seven cases of jaundice in women taking an oral contraceptive, anovlar. 1966 Br Med J pmid:5907316
Koskelo P et al. Urinary excretion of porphyrin precursors and coproporphyrin in healthy females on oral contraceptives. 1966 Br Med J pmid:5908712
Parbhoo SP and Johnston ID Effects of oestrogens and progestogens on gastric secretion in patients with duodenal ulcer. 1966 Gut pmid:5334355
Schumacher GF Acute phase protein in serum of women using hormonal contraceptives. 1966 Science pmid:4161891
Tamaoka T [Urinary gonadotropin in gynecology with special reference to adrenocortical function]. 1966 Nihon Naibunpi Gakkai Zasshi pmid:4290730
Jones RC et al. An assay for progestagens by the intravenous route. 1966 Steroids pmid:5962978
Ecker JA et al. Thrombosis of the hepatic veins. "The Budd-Chiari syndrome"--a possible link between oral contraceptives and thrombosis formation. 1966 Am. J. Gastroenterol. pmid:4952754
Takano K et al. Teratogenic effect of chlormadinone acetate in mice and rabbits. 1966 Proc. Soc. Exp. Biol. Med. pmid:4160506
Wynn V and Doar JW Some effects of oral contraceptives on carbohydrate metabolism. 1966 Lancet pmid:4162055
Maqueo M et al. Morphology of the cervix in women treated with synthetic progestins. 1966 Am. J. Obstet. Gynecol. pmid:4162849
Kobayashi F and Miyake T [Biological activity of chlormadinone acetate (3). Effects of prenatal administration on the sexual function in rats]. 1966 Nihon Naibunpi Gakkai Zasshi pmid:4165124
Ringler I Efficacy of topically applied progestational agents. 1966 Steroids pmid:4163760
Hayashi K et al. [First case of steroid jaundice caused by norethindrone and mestranol in Japan]. 1966 Nippon Sanka Fujinka Gakkai Zasshi pmid:6009965
Folman Y and Pope GS The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. 1966 J. Endocrinol. pmid:5901836
Whitelaw MJ et al. Irregular menses, amenorrhea, and infertility following synthetic progestational agents. 1966 JAMA pmid:5951886
Utsumi K et al. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B). 1966 Acta Pathol. Jpn. pmid:6012525
Andrews MC et al. A comparative study of sequential and simultaneous estrogen-progestogen cyclic medication. 1966 Am. J. Obstet. Gynecol. pmid:5914606
Carruthers ME et al. Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives. 1966 J. Clin. Pathol. pmid:5919365
Newland DO et al. Effectiveness of a sequential oral contraceptive tablet. 1966 Obstet Gynecol pmid:5925039
Whalen RE et al. Virilization of female rats by prenatally administered progestin. 1966 Endocrinology pmid:5935508
Kaiser J et al. Sequential and combined therapy in oral contraception. Mode of action and efficiency. 1966 Acta Obstet Gynecol Scand pmid:5937295
Douglas Ringrose CA et al. The effects of the administration and subsequent withdrawal of norethindrone and mestranol (Ortho-Novum) therapy on egg production in the chicken. 1966 Am. J. Obstet. Gynecol. pmid:5948252
Hilliard J et al. Norethindrone blockade of pituitary gonadotropin release; counteraction by estrogen. 1966 Endocrinology pmid:5948422
Hilliard J et al. Norethindrone blockade of LH release to intrapituitary infusion of hypothalamic extract. 1966 Endocrinology pmid:5921771
Gregg WI Galactorrhea after contraceptive hormones. 1966 N. Engl. J. Med. pmid:5949006
Brohult J and Westgren A Liver metabolism and contraceptive steroids. 1966 Acta Obstet Gynecol Scand pmid:5958394
Anberg A Hepatic influence of oral contraceptives. 1966 Acta Obstet Gynecol Scand pmid:5958395
Aurell M et al. Serum lipids and lipoproteins during long-term administration of an oral contraceptive. 1966 Lancet pmid:4158896
Pulkkinen MO Side effects of oral contraceptives. 1966 Acta Obstet Gynecol Scand pmid:5958396
Nilsson L et al. Side effects of oral contraceptives. An investigation of 4 gestagens using a double blind crossover technique. 1966 Acta Obstet Gynecol Scand pmid:5959366
Fiorino S et al. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders]. 1966 Quad Clin Ostet Ginecol pmid:5988967
Felding C The effect of anovular treatment on the renal pelvis and ureter. 1966 Acta Obstet Gynecol Scand pmid:5959367
Hutcherson WP et al. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg. 1966 Jan-Feb Fertil. Steril. pmid:5901012
Mollica G [Histochemical findings on the genital apparatus of the rat after prolonged treatment with norethindrone]. 1966 Jan-Feb Arch Ostet Ginecol pmid:5947309
Sermann R et al. [Morphofunctional relations of the genital apparatus of the rat with the diencephalo-hypophyseal axis after treatment with norethisterone]. 1966 Jan-Feb Arch Ostet Ginecol pmid:5947312
Greenblatt RB et al. A new progestogen: the 18-homologue of norethisterone. 1966 Jul-Aug Clin. Pharmacol. Ther. pmid:5939972
Taber BZ A pharmacologic comparison of norethindrone and chlormadinone acetate. 1966 Jul-Sep Int. J. Fertil. pmid:4165373
Banks AL et al. The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations. 1966 Jul-Sep Int. J. Fertil. pmid:5967993
Statzer DE et al. An evaluation of norethindrone 2 mg. with mestranol 0.1 mg. in control of conception. 1966 Mar-Apr Fertil. Steril. pmid:5907046